Re:Dean Kamen: Healthcare Debate "Backward Looking"
by blasdel on Friday August 07, 2009 @05:25PM
(#748578)
The drug companies spend almost nothing on R&D, not compared to what they spend on consumer advertising, marketing to doctors, regulatory compliance, lobbying, civil defense lawyering, and patent lawyering.
[ Parent
| on HN ]
Re:Dean Kamen: Healthcare Debate "Backward Looking"
by yummyfajitas on Friday August 07, 2009 @11:21PM
(#748930)
Typically 15-20% of their expenses are spent on R&D. The cost of marketing is also about 15-20%. This is roughly the same as any large tech company. Compare Merck and Johnson&Johnson to Google or Intel.
http://www.google.com/finance?q=NYSE:MRK&fstype=ii
http://www.google.com/finance?q=NYSE:JNJ&fstype=ii
Re:Dean Kamen: Healthcare Debate "Backward Looking"
by profgubler on Friday August 07, 2009 @10:05PM
(#748866)
Marketing does not raise the cost of Healthcare and medicine, but those lawyers you mention sure do.